Skip to main content
. 2019 Jan 9;8(2):629–642. doi: 10.1002/cam4.1966

Figure 6.

Figure 6

Forest plots of RR of grade 3‐5 AEs associated with nivolumab vs docetaxel (including subgroup analysis of 10 most‐reported grade 3‐5 AEs according to the combination of both arms)